GGrantIndex
← Leaderboards

Eric Douglas Austin

Vanderbilt University

$6,099,747
Attributed
$9,510,776
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY201025
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,910,776 · 6
FDA$1,600,000 · 1

By mechanism

R01$6,808,165 · 3
T32$1,488,759 · 1
K23$652,050 · 1
R34$553,802 · 1
R13$8,000 · 1

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Lung

Research focus

LungCohortPulmonary Arterial HypertensionPublishingPathogenesisUnited States National Institutes Of HealthWomanAdultChildhoodMutationMetabolismAndrogensMediatingFemaleRisk FactorsLinkEstrogensBmpr2 GeneMaleEstrogen MetabolismEstrogen AntagonistsGonadal Steroid HormonesResearch TrainingBlood Vessels

Grant awards (23)

Clinical and Biochemical Features of Metabolic Dysregulation in Formerly Preterm Children$712,365
R01 · FY2025 · HL · contact PI
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals$400,000
R01 · FY2025 · FD
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease$366,737
T32 · FY2025 · HL
MhOVE-PPH Study: Mobile health interventiOn to improVe Exercise in Pediatric PH$260,614
R34 · FY2025 · HL · contact PI
Clinical and Biochemical Features of Metabolic Dysregulation in Formerly Preterm Children$761,618
R01 · FY2024 · HL · contact PI
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals$400,000
R01 · FY2024 · FD
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease$387,294
T32 · FY2024 · HL
MhOVE-PPH Study: Mobile health interventiOn to improVe Exercise in Pediatric PH$293,188
R34 · FY2024 · HL · contact PI
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals$400,000
R01 · FY2023 · FD
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease$376,328
T32 · FY2023 · HL
Estrogen signaling and energy metabolism in pulmonary arterial hypertension$740,619
R01 · FY2022 · HL · contact PI
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals$400,000
R01 · FY2022 · FD
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease$358,400
T32 · FY2022 · HL
Estrogen signaling and energy metabolism in pulmonary arterial hypertension$768,635
R01 · FY2021 · HL · contact PI
Estrogen signaling and energy metabolism in pulmonary arterial hypertension$769,744
R01 · FY2020 · HL · contact PI
Estrogen signaling and energy metabolism in pulmonary arterial hypertension$724,317
R01 · FY2019 · HL · contact PI
Estrogen signaling and energy metabolism in pulmonary arterial hypertension$730,867
R01 · FY2018 · HL · contact PI
The 2015 Grover Conference$8,000
R13 · FY2015 · HL · contact PI
Variations in estrogen exposures may modify pulmonary arterial hypertension$130,410
K23 · FY2014 · HL · contact PI
Variations in estrogen exposures may modify pulmonary arterial hypertension$130,410
K23 · FY2013 · HL · contact PI
Variations in estrogen exposures may modify pulmonary arterial hypertension$130,410
K23 · FY2012 · HL · contact PI
Variations in estrogen exposures may modify pulmonary arterial hypertension$130,410
K23 · FY2011 · HL · contact PI
Variations in estrogen exposures may modify pulmonary arterial hypertension$130,410
K23 · FY2010 · HL · contact PI